Acumen Pharmaceuticals (ABOS) shares fell 75% pre-bell Friday after the company said a phase 2 clinical trial of its lead Alzheimer's drug candidate, sabirnetug, failed to meet the primary endpoint.
Alphatec (ATEC) stock was down 31% a day after the company posted Q3 financial results.
FingerMotion (FNGR) stock was 25% lower after a 2.6% loss in the prior session, when the company said it had entered into a non-binding term sheet for a potential business combination with BlueFlare Group.
Intel (INTC) shares declined 26% after the company posted a disappointing outlook for Q4 and 2027.
Reddit (RDDT) shares fell 18.5% following the company's Q3 financial results.